Authors: Corbett, JW Kresge, KJ Pan, SL Cordova, BC Klabe, RM Rodgers, JD Erickson-Viitanen, SK

Citation: Jw. Corbett et al., Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase, BIOORG MED, 11(3), 2001, pp. 309-312

Authors: Corbett, JW Pan, SL Markwalder, JA Cordova, BC Klabe, RM Garber, S Rodgers, JD Erickson-Viitanen, SK

Citation: Jw. Corbett et al., 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors, BIOORG MED, 11(2), 2001, pp. 211-214

Authors: Cocuzza, AJ Chidester, DR Cordova, BC Klabe, RM Jeffrey, S Diamond, S Weigelt, CA Ko, SS Bacheler, LT Erickson-Viitanen, SK Rodgers, JD

Citation: Aj. Cocuzza et al., 4,1-Benzoxazepinone analogues of efavirenz (Sustiva (TM)) as HIV-1 reversetranscriptase inhibitors, BIOORG MED, 11(11), 2001, pp. 1389-1392

Authors: Corbett, JW Gearhart, LA Ko, SS Rodgers, JD Cordova, BC Klabe, RM Erickson-Viitanen, SK

Citation: Jw. Corbett et al., Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors, BIOORG MED, 10(2), 2000, pp. 193-195

Authors: Corbett, JW Ko, SS Rodgers, JD Gearhart, LA Magnus, NA Bacheler, LT Diamond, S Jeffrey, S Klabe, RM Cordova, BC Garber, S Logue, K Trainor, GL Anderson, PS Erickson-Viitanen, SK

Citation: Jw. Corbett et al., Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 43(10), 2000, pp. 2019-2030

Authors: Corbett, JW Ko, SS Rodgers, JD Jeffrey, S Bacheler, LT Klabe, RM Diamond, S Lai, CM Rabel, SR Saye, JA Adams, SP Trainor, GL Anderson, PS Erickson-Viitanen, SK

Citation: Jw. Corbett et al., Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1, ANTIM AG CH, 43(12), 1999, pp. 2893-2897